House Bill 744 creates a Fertility Preservation Pilot Program funded through the Office of State Budget and Management. The bill appropriates $2.25 million in nonrecurring General Fund dollars in each year of the 2025-2027 biennium to be distributed as directed grants in equal amounts to three specified providers: Duke University School of Medicine’s Onco-Fertility Program, UNC-Chapel Hill School of Medicine’s Fertility Clinic/Fertility Preservation Program, and Atrium Health Levine Cancer Center’s REhope Cancer Fertility Treatment Program. The program would run from July 1, 2025, through June 30, 2032.
The program is designed to help people whose fertility is threatened by a cancer diagnosis or cancer treatment obtain fertility preservation and related services, including IVF, IUI, oocyte or sperm retrieval, cryopreservation, and storage. Eligibility is limited to applicants who are uninsured, whose insurance does not adequately cover these services, or whose coverage would still leave them with more than $1,000 in out-of-pocket costs, with an additional income-based criterion for households below 300% of the federal poverty level. The bill sets maximum assistance amounts, including up to $12,000 for female participants for oocyte retrieval, cryopreservation, and storage; up to $1,500 for male participants for sperm retrieval, cryopreservation, and storage; and up to $26,000 per participant for IVF or IUI services scheduled within five years of retrieval.
HB744 would affect state spending and create a new, targeted grant program rather than amend existing insurance mandates or clinical licensing laws. It directs state funds to specific medical institutions, allows up to 3% of grant funds for administration, permits funds to be reserved for future IVF or IUI services, and keeps appropriated money available until expended or June 30, 2032. The bill also requires annual reporting to legislative oversight and fiscal committees beginning in 2028, with reporting structured to comply with HIPAA and other privacy laws.
The overall sentiment reflected by the bill’s structure is supportive of fertility preservation access, especially for cancer patients facing infertility risks, and it appears to frame the issue as a health access and financial assistance measure. There is no recorded committee debate or vote history in the provided materials, so no direct opposition or amendment activity is available. The main likely points of contention are the use of state funds for fertility services, the selection of only three grantee institutions, the income and insurance eligibility limits, and the size and duration of the appropriations relative to the number of people served.
HB744 would create a new state-funded fertility preservation grant program administered through the Office of State Budget and Management and would appropriate $2.25 million annually in nonrecurring General Fund dollars for the 2025-2027 biennium. It would not directly change insurance coverage requirements, but it would provide public funding for fertility-related services for eligible cancer patients and require annual reporting to legislative oversight bodies. The bill also establishes a multi-year pilot structure through 2032 and authorizes the use of state funds for treatment, preservation, storage, and related administrative costs at three named medical institutions.
The bill appears to have a generally favorable, access-oriented policy intent, focusing on helping cancer patients preserve fertility when treatment threatens future reproductive capacity. Because there are no committee transcripts or recorded votes in the provided materials, there is no documented public debate to indicate formal support or opposition. The absence of voting history suggests the bill was still early in the legislative process at the time of referral.
Potential areas of contention include whether state dollars should subsidize fertility preservation and IVF/IUI services, whether the program should be limited to three specific academic and health-system providers, and whether the eligibility rules are too narrow or too broad. The income cap, insurance-based restrictions, and the $1,000 out-of-pocket threshold may draw scrutiny from those concerned about access or targeting. Others may question the scale of the appropriation, the long duration of the pilot, and the decision to reserve funds for future services rather than spend them immediately.